- Universal Health Services Inc UHS reported Q2 revenue of $3.32 billion, +3.9% Y/Y, slightly above the consensus of $3.28 billion.
- The company reported an adjusted EPS of $2.20, down from $3.76 a year ago and missing the consensus of $2.35, but higher than the management guidance of $2.05 - $2.15.
- Acute care hospitals owned adjusted admissions decreased by 0.7%, and adjusted patient days increased by 1.8% Y/Y.
- Net revenues generated from acute care services on the same facility basis increased by 3.3%.
- In behavioral health care facilities on a same facility basis, adjusted admissions decreased by 0.1%, and adjusted patient days increased 0.7%.
- Adjusted EBITDA reached $382.56 million, and the margin declined from 17.9% to 11.5%.
- Universal Health Services continues to experience a shortage of nurses, other clinical staff, and support personnel at acute care and behavioral health care hospitals.
- The company revised guidance assuming that staffing vacancies and the corresponding premium pay expenditures will continue declining in the year's second half.
- It anticipates that non-COVID patient volumes will incrementally improve, although both at a slower pace than the original forecast.
- Price Action: UHS shares closed 4.61% lower at $104.84 during the post-market session on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in